IFN-α9 activators are a category of chemicals that specifically target and modulate the activity of interferon alpha-9 (IFN-α9), an important protein in the immunological response system. Interferons, including IFN-α9, are a group of signaling proteins released by host cells in response to the presence of several pathogens, such as viruses, bacteria, and parasites. The role of IFN-α9 in the immune system is crucial as it is involved in the signaling pathways that activate immune responses. The activators of IFN-α9 are designed to either increase the production or enhance the function of IFN-α9 through various molecular mechanisms. These could include direct binding to the protein or its receptor, modulation of its gene expression, or alteration of its signaling pathways. The molecular structures of these activators are diverse, encompassing small molecules, peptides, or other biologically active agents. The development of these activators requires a deep understanding of the biochemistry and biology of IFN-α9, including knowledge of its molecular structure, signaling pathways, and the biological processes it influences.
The interaction of IFN-α9 activators with the immune system is a complex and intricate process. IFN-α9 is part of the body's innate immune response, the first line of defense against pathogens. When pathogens are detected, IFN-α9 is produced and released by affected cells, initiating a protective response. This response involves the activation of a range of genes that collectively work to inhibit the spread of the pathogen. The activators of IFN-α9 play a role in this process by enhancing the production or activity of IFN-α9, thereby amplifying the immune response. This amplification can involve a variety of biological processes, including the upregulation of antigen presentation, activation of natural killer cells, and the stimulation of other immune signaling pathways. Research in this field is focused on understanding the detailed mechanisms by which these activators influence IFN-α9 and the subsequent cascade of immune responses. This research is primarily driven by an interest in the fundamental biological processes and the intricate interplay between different components of the immune system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
A mimetic of viral double-stranded RNA, which can trigger a host cell antiviral response, including the production of IFN-α subtypes. | ||||||
Loxoribine | 121288-39-9 | sc-203118 sc-203118A | 25 mg 100 mg | $124.00 $390.00 | 1 | |
An agonist of endosomal Toll-like receptor 7 that can induce the production of IFN-α by mimicking viral RNA. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
A synthetic ligand for Toll-like receptor 7, which can stimulate the innate immune response and potentially IFN-α expression. | ||||||
Isoprinosine | 36703-88-5 | sc-279232 sc-279232A sc-279232B | 10 mg 100 mg 1 g | $120.00 $210.00 $270.00 | ||
An immunomodulatory agent which may enhance the immune response and potentially upregulate IFN-α synthesis. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
A diuretic that can modulate endosomal pH and may influence endosomal Toll-like receptor signaling, potentially affecting IFN-α production. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
A compound known to interfere with endosomal acidification, which can impact Toll-like receptor signaling and subsequent IFN-α production. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
A guanosine analogue that can have broad-spectrum antiviral effects and may induce IFN-α via immune modulation. | ||||||